Daniel K. Spiegelman
CIK: 0001238403
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 26, 2026VTVT
vTv Therapeutics Inc.
Award(A)DirectDirector stock option (right to buy)
6K shares at avg. $35.08- - Jun 8, 2026MAZE
Maze Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
18K shares- - May 21, 2026SPRB
SPRUCE BIOSCIENCES, INC.
Award(A)DirectStock Option (Right to Buy)
1.7K shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
Award(A)DirectStock Option (Right to Buy)
400 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
Disposition(D)DirectStock Option (Right to Buy)
400 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
Disposition(D)DirectStock Option (right to buy)
88 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
Award(A)DirectStock Option (Right to Buy)
458 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
Disposition(D)DirectStock Option (Right to Buy)
458 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
Award(A)DirectStock Option (right to buy)
88 shares- - Sep 22, 2025MAZE
Maze Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
18K shares- - Jul 22, 2025SPRB
SPRUCE BIOSCIENCES, INC.
Award(A)DirectStock Option (Right to Buy)
30K shares- - Jun 10, 2025VTVT
vTv Therapeutics Inc.
Award(A)DirectDirector stock option (right to buy)
4K shares at avg. $16.59- - May 29, 2025KYTX
Kyverna Therapeutics, Inc.
Award(A)Direct16.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 26, 2026 |  VTVT vTv Therapeutics Inc. | Award(A) Director stock option (right to buy) | 6,000 | $35.08 | - | Direct |
| Jun 8, 2026 |  MAZE Maze Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| May 21, 2026 |  SPRB SPRUCE BIOSCIENCES, INC. | Award(A) Stock Option (Right to Buy) | 1,700 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Award(A) Stock Option (Right to Buy) | 400 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Disposition(D) Stock Option (Right to Buy) | 400 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Disposition(D) Stock Option (right to buy) | 88 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Award(A) Stock Option (Right to Buy) | 458 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Disposition(D) Stock Option (Right to Buy) | 458 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Award(A) Stock Option (right to buy) | 88 | - | - | Direct |
| Sep 22, 2025 | MAZE Maze Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| Jul 22, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Award(A) Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| Jun 10, 2025 | VTVT vTv Therapeutics Inc. | Award(A) Director stock option (right to buy) | 4,000 | $16.59 | - | Direct |
| May 29, 2025 |  KYTX Kyverna Therapeutics, Inc. | Award(A) | 16,634 | - | - | Direct |
1-13 of 13 transactions
About SPIEGELMAN DANIEL K
SPIEGELMAN DANIEL K (SEC CIK 0001238403) files insider reports with the SEC as Director of vTv Therapeutics Inc. (VTVT), Director of Maze Therapeutics, Inc. (MAZE) and Director of SPRUCE BIOSCIENCES, INC. (SPRB). Signal8 also holds filings tied to 1 other company.
Signal8 holds 9 ownership filings by SPIEGELMAN DANIEL K (1 Form 3, 8 Form 4), filed between Jan 30, 2025 and Jun 29, 2026. Those filings report 13 transactions, from May 29, 2025 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SPIEGELMAN DANIEL K's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by SPIEGELMAN DANIEL K
- Jun 26, 2026: Grant or award of VTVT derivative securities (Form 4, code A).
- Jun 8, 2026: Grant or award of MAZE derivative securities (Form 4, code A).
- May 21, 2026: Grant or award of SPRB derivative securities (Form 4, code A).
- Dec 11, 2025: Grant or award of SPRB derivative securities (Form 4, code A).
- Dec 11, 2025: Disposition to issuer transactions of SPRB derivative securities (2 lines, Form 4, code D).
Other insiders filing for vTv Therapeutics Inc. (VTVT)
- BAKER BROS. ADVISORS LP, Director
- AKKARAJU SRINIVAS, Director
- Al-Marzooqi Fahed, Director
- Phillips Anne M., Director
- Tung Michael Stephen, EVP & CFO
- SEKHRI PAUL J, Pres, CEO and Exec Chairperson